Tralokinumab

ATC D11AH07 · 5 markets · 9 records

Tralokinumab 5 markets · 9 records Forms

US 2 records · 2 strengths

300 mg/2 mLinjectionAdbry also in GB
150 mginjectionAdbry also in ES

GB 2 records · 2 strengths

300 mg/2 mLinjectionAdtralza 300mg/2ml solution for injection pre-filled pens also in US
150 mg/1 mLinjectionAdtralza 150mg/1ml solution for injection pre-filled syringes

CA 2 records · 2 strengths

150 mgliquidADTRALZA
150 mg/1 mLliquidADTRALZA

ES 2 records · 2 strengths

150 mginjectionADTRALZA PRECARGADA also in US
300 mginjectionADTRALZA PRECARGADA

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 ADTRALZA

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.